当前位置: 首页 > 期刊 > 《健康之路》 > 20146
编号:13678727
髓源抑制性细胞与临床抗肿瘤免疫治疗(2)
http://www.100md.com 2014年6月1日 《健康之路》 20146
     参考文献

    [1] Liu Q,Zhang C,Sun A,et al.Tumor-educated CD11b highIa low regulatory dendritic cells suppress T cell response through arginase I[J].J Immunol,2009,182(10):6207-6216

    [2] Chung DJ,Rossi M,Romano E,et al.Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells[J].Blood,2009,114(3):555-563

    [3] Nardin A,Abastado JP.Macrophages and cancer[J].Front Biiosci,2008,113(3):494-505

    [4] Hoechst B,Ormandy LA,Ballmaier M,et al.A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells.Gastroenterology.2008;135(1):234-243

    [5] Yang R,Cai Z,Zhang Y,et al.CD80 in immune suppression by mouse ovarian carcinoma-associated GR1+CD11b+ myeloid cells[J].Cancer Res,2006,66(13):6807-6815

    [6] Serafini P,Mgebroff S,Noonan K,et al.Myeloid-derived suppressor cells promote cross tolerance in B-cell lymphoma by expanding regulatory T cells[J].Cancer Res,2008,68(13):5439-5449

    [7] Movahedi K,Guilliams M,Van den Bossche J,et al.Identification of discrete tumor induced myeloid-derived suppressor cell subpopulations with distinct T-cell suppressive activity[J].Blood,2008,111(8):4233-4244, http://www.100md.com(孙智香 张明 孙智娟)
上一页1 2